BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23232185)

  • 1. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
    Akl H; Bultynck G
    Biochim Biophys Acta; 2013 Apr; 1835(2):180-93. PubMed ID: 23232185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of Ca
    Ando H; Kawaai K; Bonneau B; Mikoshiba K
    Adv Biol Regul; 2018 May; 68():64-76. PubMed ID: 29287955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling.
    Bittremieux M; Parys JB; Pinton P; Bultynck G
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1364-78. PubMed ID: 26772784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
    Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
    J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2-Protein Family as Modulators of IP
    Ivanova H; Vervliet T; Monaco G; Terry LE; Rosa N; Baker MR; Parys JB; Serysheva II; Yule DI; Bultynck G
    Cold Spring Harb Perspect Biol; 2020 Apr; 12(4):. PubMed ID: 31501195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.
    Monaco G; Vervliet T; Akl H; Bultynck G
    Cell Mol Life Sci; 2013 Apr; 70(7):1171-83. PubMed ID: 22955373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
    Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
    J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP
    Roest G; La Rovere RM; Bultynck G; Parys JB
    Adv Exp Med Biol; 2017; 981():149-178. PubMed ID: 29594861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca(2+) transfer from the ER to mitochondria: when, how and why.
    Rizzuto R; Marchi S; Bonora M; Aguiari P; Bononi A; De Stefani D; Giorgi C; Leo S; Rimessi A; Siviero R; Zecchini E; Pinton P
    Biochim Biophys Acta; 2009 Nov; 1787(11):1342-51. PubMed ID: 19341702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Bcl-2-IP
    Distelhorst CW
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IP
    Parys JB; Bultynck G; Vervliet T
    Prog Mol Subcell Biol; 2021; 59():215-237. PubMed ID: 34050869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites.
    Pinton P; Giorgi C; Pandolfi PP
    Cell Death Differ; 2011 Sep; 18(9):1450-6. PubMed ID: 21475307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights in the IP
    Parys JB; Vervliet T
    Adv Exp Med Biol; 2020; 1131():243-270. PubMed ID: 31646513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling.
    Eckenrode EF; Yang J; Velmurugan GV; Foskett JK; White C
    J Biol Chem; 2010 Apr; 285(18):13678-84. PubMed ID: 20189983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Mechanisms of Endoplasmic Reticulum Resident IP3 Receptors.
    Shah SZA; Zhao D; Khan SH; Yang L
    J Mol Neurosci; 2015 Aug; 56(4):938-948. PubMed ID: 25859934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release.
    Giorgi C; Ito K; Lin HK; Santangelo C; Wieckowski MR; Lebiedzinska M; Bononi A; Bonora M; Duszynski J; Bernardi R; Rizzuto R; Tacchetti C; Pinton P; Pandolfi PP
    Science; 2010 Nov; 330(6008):1247-51. PubMed ID: 21030605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 3 IP
    Rosa N; Sneyers F; Parys JB; Bultynck G
    Int Rev Cell Mol Biol; 2020; 351():101-148. PubMed ID: 32247578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-xL acts as an inhibitor of IP
    Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
    Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.